News
The company’s board has passed a special resolution to change its name from Lenskart Solutions Private Limited to Lenskart ...
However, the headline-grabbing rate and CRR cuts came with a crucial caveat: the RBI shifted its policy stance again to 'Neutral' from 'Accommodative'. This change in stance, in just one meeting after ...
CNBC's Jim Cramer walked investors through next week on Wall Street, pinpointing the latest consumer price index report and a number of investor days, including one from BlackRock. The 'Mad Money' ...
Good morning, tech fam; here are some quick tech updates for you to catch up on! What’s New Today: Speedata created an APU which is designed to accelerate big d ...
Hi, it’s Ryan Gould, taking some time out from SuperReturn in Berlin to bring you the best bits of a recent chat I had with a ...
A concoction of factors — war, inflation, lower earnings — has led to lackluster performance for equities so far this year.
Analysts have set 12-month price targets for CME Group, revealing an average target of $276.38, a high estimate of $305.00, ...
As the exclusive distributor of the Tape D API, Nasdaq is enhancing essential transparency and access to an increasingly complex private company landscape. Now available to Nasdaq clients through API ...
Zepto CEO Aadit Palicha has spent a lot of time in the US in the past couple of weeks to discuss a potential fundraise. Zepto ...
The pending Nippon Steel deal would be unusual in granting the U.S. government some control over a private company—models ...
The pending Nippon Steel deal would be unusual in granting the U.S. government some control over a private company — models ...
Kymera Therapeutics (KYMR) stock gains as promising Phase 1 results for KT-621, an oral anti-inflammatory drug, leads to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results